doi: 10.1038/bjc.1991.203.
Growth inhibition observed following administration of an LHRH agonist to a clonal variant of the MCF-7 breast cancer cell line is accompanied by an accumulation of cells in the G0/G1 phase of the cell cycle
Affiliations
- PMID: 1906293
- PMCID: PMC1972522
- DOI: 10.1038/bjc.1991.203
Item in Clipboard
Growth inhibition observed following administration of an LHRH agonist to a clonal variant of the MCF-7 breast cancer cell line is accompanied by an accumulation of cells in the G0/G1 phase of the cell cycle
Br J Cancer.
1991 Jun.
Free PMC article
No abstract available
Similar articles
-
Interleukin-1 alpha differentially synchronizes estrogen-dependent and estrogen-independent human breast cancer cells in the G0/G1 phase of the cell cycle.Anticancer Res. 1991 Jan-Feb;11(1):25-31. Anticancer Res. 1991. PMID: 1826821
-
Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells.Eur J Cancer Clin Oncol. 1985 Dec;21(12):1493-9. doi: 10.1016/0277-5379(85)90244-5. Eur J Cancer Clin Oncol. 1985. PMID: 3938397
-
Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2336-9. doi: 10.1073/pnas.89.6.2336. Proc Natl Acad Sci U S A. 1992. PMID: 1312718 Free PMC article.
-
G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6).Anticancer Res. 2001 Jul-Aug;21(4A):2393-403. Anticancer Res. 2001. PMID: 11724298
-
Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha.Mol Endocrinol. 1993 Sep;7(9):1121-32. doi: 10.1210/mend.7.9.8247014. Mol Endocrinol. 1993. PMID: 8247014
Cited by
-
Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters.Breast Cancer Res Treat. 1993;25(1):37-46. doi: 10.1007/BF00662399. Breast Cancer Res Treat. 1993. PMID: 8390871
-
Influence on antiproliferative activity of structural modification and conjugation of gonadotropin-releasing hormone (GnRH) analogues.Cell Prolif. 2000 Oct;33(5):275-85. doi: 10.1046/j.1365-2184.2000.00180.x. Cell Prolif. 2000. PMID: 11063130 Free PMC article.
-
Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogen-dependent MXT mouse mammary cancers: correlations between growth characteristics and EGF receptor content of tumors.Breast Cancer Res Treat. 1996;40(2):129-39. doi: 10.1007/BF01806208. Breast Cancer Res Treat. 1996. PMID: 8879679
-
Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells.J Cancer Res Clin Oncol. 1994;120(10):605-9. doi: 10.1007/BF01212815. J Cancer Res Clin Oncol. 1994. PMID: 7929532 Free PMC article.
-
Fertility preservation in reproductive-age women facing gonadotoxic treatments.Curr Oncol. 2015 Aug;22(4):e294-304. doi: 10.3747/co.22.2334. Curr Oncol. 2015. PMID: 26300680 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
